KELCI TKACH: Open Payments
NPI 1538595541 · LEHIGHTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,881 in 100 payments from 21 companies in 2025. Trend: 2023 $1,642 · 2024 $2,197 · 2025 $1,881
Food & beverage: $1,782Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $288 |
| Janssen Biotech, Inc. | 14 | $282 |
| Madrigal Pharmaceuticals | 14 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $177 |
| Ardelyx, Inc. | 6 | $176 |
| Aimmune Therapeutics, Inc. | 5 | $107 |
| Lilly USA, LLC | 4 | $85 |
| Intercept Pharmaceuticals, Inc. | 4 | $78 |
| QOL Medical, LLC | 4 | $64 |
| Ipsen Biopharmaceuticals, Inc | 4 | $62 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, ENTYVIO, LINZESS, ZENPEP, OMVOH, OCALIVA.
Industry payments across PA — which companies pay providers there.
